Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold

Cited by (637)

Items 101–200 of 637

1. Updating Cost Effectiveness Analyses in Orthopedic Surgery: Resilience of the $50,000 per QALY Threshold
   Benedict Uchenna Nwachukwu, Kevin John Bozic · 2015 · The Journal of Arthroplasty
2. Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study
   Ya‐Chen Tina Shih, Jörge E. Cortes, Hagop M. Kantarjian · 2019 · The Lancet Haematology
3. Cost-effectiveness of prenatal screening strategies for congenital heart disease
   Nelangi Marie Pinto, Richard E. Nelson, Michael D. Puchalski, Torri D. Metz, Kenneth J. Smith · 2013 · Ultrasound in Obstetrics and Gynecology
4. Cost–effectiveness of pre-exposure prophylaxis for HIV
   Bruce R. Schackman, Ashley A. Eggman · 2012 · Current Opinion in HIV and AIDS
5. Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster
   Tracy A. Lieu, Gary Thomas Ray, Ismael R. Ortega‐Sanchez, KEN P. KLEINMAN, Donna Rusinak, Lisa A. Prosser · 2009 · PharmacoEconomics
6. Effect of malignancy rates on cost-effectiveness of routine gene expression classifier testing for indeterminate thyroid nodules
   James X. Wu, Raymond Wing Moon Lam, Mary R. Levin, Jianyu Rao, Peggy S. Sullivan, Michael W. Yeh · 2015 · Surgery
7. The Cost-Effectiveness of Anterior Cruciate Ligament Reconstruction in Competitive Athletes
   Bruce A. Stewart, Amit Mukesh Momaya, Marc D. Silverstein, David M. Lintner · 2016 · The American Journal of Sports Medicine
8. Success stories in genomic medicine from resource-limited countries
   Konstantinos A. Mitropoulos, Hayat S Al Jaibeji, Diego A. Forero, Paul Laissue, Ambroise Wonkam, Catalina López-Correa, Zahurin Mohamed, Wasun Chantratita, Ming Ta Michael Lee, Adrián LLerena et al. · 2015 · Human Genomics
9. The Cost-Effectiveness of Screening Men Who Have Sex With Men for Rectal Chlamydial and Gonococcal Infection to Prevent HIV Infection
   Harrell W. Chesson, Kyle T. Bernstein, Thomas L. Gift, Julia L. Marcus, Sharon S. Pipkin, Charlotte Kathleen Kent · 2013 · Sexually Transmitted Diseases
10. Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State
    Yao Ding, John D. Thompson, Lisa J. Kobrynski, Jelili A. Ojodu, Guisou Zarbalian, Scott Dennis Grosse · 2016 · The Journal of Pediatrics
11. Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression
    Christian R. C. Kouakou, Thomas G. Poder · 2021 · The European Journal of Health Economics
12. Cost–Effectiveness Analysis of Genotyping for HLA-B*5801 and an Enhanced Safety Program in Gout Patients Starting Allopurinol in Singapore
    Di Dong, Wei Chuen Tan‐Koi, Gim Gee Teng, Eric Andrew Finkelstein, Cynthia Sung · 2015 · Pharmacogenomics
13. Cost of Major Complications After Liver Resection in the United States
    Jay J. Idrees, Fabian McCartney Johnston, Joseph K. Canner, Mary E. Dillhoff, Carl Richard Schmidt, Elliott Richard Haut, Timothy Michael Pawlik · 2017 · Annals of Surgery
14. Further Limiting Bisphenol A In Food Uses Could Provide Health And Economic Benefits
    Leonardo Trasande · 2014 · Health Affairs
15. Cost-effectiveness of Surgical Treatment for Degenerative Spondylolisthesis and Spinal Stenosis
    James Shields Harrop, Alan S. Hilibrand, Kathryn E. Mihalovich, Joseph R. Dettori, Jens Robert Chapman · 2014 · Spine
16. Determinants of Change in the Cost-effectiveness Threshold
    Mike Paulden, James F. O’Mahony, Christopher J. McCabe · 2016 · Medical Decision Making
17. Phthalate exposure from plastics and cardiovascular disease: global estimates of attributable mortality and years life lost
    Sara Hyman, Jonathan M Acevedo, Chiara Giannarelli, Leonardo Trasande · 2025 · EBioMedicine
18. How to assess the value of medicines?
    Steven Simoens · 2010 · Frontiers in Pharmacology
19. Patient-Reported Outcomes and Survivorship in Radiation Oncology: Overcoming the Cons
    Farzan Siddiqui, Arthur K. Liu, Deborah Watkins Bruner, Benjamin Movsas · 2014 · Journal of Clinical Oncology
20. Digital interventions in mental health: Evidence syntheses and economic modelling
    Gega, Lina, Jankovic, Dina, Saramago, Pedro, Marshall, David, Dawson, Sarah, Brabyn, Sally, Nikolaidis, Georgios F, Melton, Hollie, Churchill, Rachel, Bojke, Laura · 2022 · Health Technology Assessment
21. Decision analysis, economic evaluation, and newborn screening: challenges and opportunities
    Lisa A. Prosser, Scott Dennis Grosse, Alex R. Kemper, Beth Anne Tarini, James M. Perrin · 2012 · Genetics in Medicine
22. An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model
    Richard E. Nelson, Makoto Jones, Molly K. Leecaster, Matthew H. Samore, William R. Ray, Angela Csaki Huttner, Benedikt David Huttner, Karim Khader, Vanessa W Stevens, Dale N. Gerding et al. · 2016 · PLoS ONE
23. Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study
    Tan Nhut Doan, Greg James Fox, Michael T. Meehan, Nick Scott, Romain R. Ragonnet, Kerri A. Viney, James McCracken Trauer, Emma Sue McBryde · 2018 · Journal of Antimicrobial Chemotherapy
24. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.
    Barbosa, Carolina, Fraser, Hannah, Hoerger, Thomas J., Leib, Alyssa, Havens, Jennifer R., Young, April, Kral, Alex, Page, Kimberly, Evans, Jennifer, Zibbell, Jon et al. · 2019 · Addiction
25. Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands
    Maiwenn Al, Leona Hakkaart‐van Roijen, Siok Swan Tan, Jan Bakker · 2010 · Critical Care
26. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review
    Anna Puggina, Amy R. Broumas, Walter Ricciardi, Stefania Boccia · 2015 · European Journal of Public Health
27. Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment
    Zhibin ZC Chen, Danny Liew, Patrick Kwan · 2016 · Neurology
28. Cost-analysis and quality of life after laparoscopic and robotic ventral mesh rectopexy for posterior compartment prolapse: a randomized trial
    Johanna Mäkelä‐Kaikkonen, Tero Rautio, Arto E. Ohinmaa, Sari Koivurova, Pasi Petteri Ohtonen, Harri Sintonen, Jyrki Tapani Mäkelä · 2019 · Techniques in Coloproctology
29. The cost‐effectiveness of brief intervention versus brief treatment of Screening, Brief Intervention and Referral to Treatment (SBIRT) in the United States
    Barbosa, Carolina, Cowell, Alexander, Dowd, William, Landwehr, Justin, Aldridge, Arnie, Bray, Jeremy · 2017 · Addiction
30. Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome
    Yun Wang, B.P.Y. Yan, Danny Liew, Vivian Wing Yan Lee · 2017 · The Pharmacogenomics Journal
31. Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data
    Vivek Yerrapu Reddy, Ronald L. Akehurst, Meghan B. Gavaghan, Stacey L. Amorosi, David R. Holmes · 2019 · Journal of the American Heart Association
32. Evaluating the Cost-Effectiveness of the ABCDE Bundle: Impact of Bundle Adherence on Inpatient and 1-Year Mortality and Costs of Care*
    Ashley W. Collinsworth, Elisa L. Priest, Andrew L. Masica · 2020 · Critical Care Medicine
33. Cost Efficacy of Rapid Whole Genome Sequencing in the Pediatric Intensive Care Unit
    Erica Sanford Kobayashi, Bryce M. Waldman, Branden M. Engorn, Katherine Perofsky, Erika T. Allred, Benjamin J. Briggs, Chelsea Gatcliffe, Nanda Ramchandar, Jeffrey J. Gold, Ami Doshi et al. · 2022 · Frontiers in Pediatrics
34. Cost Per DALY Averted Thresholds for Low- and Middle-Income Countries: Evidence From Cross Country Data
    Jessica Ochalek, James R.S. Lomas, Karl Claxton · 2017
35. Economic evaluations of audit and feedback interventions: a systematic review
    Moore, Lynne, Guertin, Jason Robert, Tardif, Pier-Alexandre, Ivers, Noah Michael, Hoch, Jeffrey, Conombo, Blanchard, Antony, Jesmin, Stelfox, Henry Thomas, Berthelot, Simon, Archambault, Patrick et al. · 2022 · BMJ Quality & Safety
36. Cost-Utility Analysis of the Housing and Health Intervention for Homeless and Unstably Housed Persons Living with HIV
    David R. Holtgräve, Richard J. Wolitski, Sherri L. Pals, Angela A. Aidala, Daniel P. Kidder, David Vos, Scott Royal, Nkemdiri Iruka, Kate Briddell, Ron D. Stall et al. · 2012 · AIDS and Behavior
37. Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection
    Raghu U. Varier, Eman Biltaji, Kenneth J. Smith, Mark S. Roberts, M. Kyle Jensen, Josiane Lafleur, Richard E. Nelson · 2014 · Clinical Microbiology and Infection
38. Cost-Effectiveness Analysis of The Real Cost Campaign's Effect on Smoking Prevention
    Anna J. MacMonegle, James M. Nonnemaker, Jennifer C. Duke, Matthew C. Farrelly, Xiaoquan Zhao, Janine C. Delahanty, Alexandria A. Smith, Pamela Rao, Jane Appleyard Allen · 2018 · American Journal of Preventive Medicine
39. Defining High Risk: Cost-Effectiveness of Extended-Duration Thromboprophylaxis Following Major Oncologic Abdominal Surgery
    James Christopher Iannuzzi, Aaron S. Rickles, Kristin N. Kelly, Fergal J. Fleming, James G. Dolan, John R.T. Monson, Katia Noyes · 2013 · Journal of Gastrointestinal Surgery
40. Cost Effectiveness of Medication Adherence-Enhancing Interventions: A Systematic Review of Trial-Based Economic Evaluations
    Edwin J. M. Oberjé, Reina J.A. de Kinderen, Silvia Evers, Cees M. J. van Woerkum, Marijn de Bruin · 2013 · PharmacoEconomics
41. Seven-year cost-effectiveness of ProDisc-C total disc replacement: results from investigational device exemption and post-approval studies
    Kris E. Radcliff, Jason H. Lerner, Chao Yang, Thierry Bernard, Jack E. Zigler · 2016 · Journal of Neurosurgery Spine
42. Ten Million Calls and Counting: Progress and Promise of Tobacco Quitlines in the U.S.
    Michael C. Fiore, Timothy B. Baker · 2021 · American Journal of Preventive Medicine
43. Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis
    George A. Scangas, Aaron Kyle Remenschneider, Brooke M. Su‐Velez, Mark G. Shrime, Ralph B. Metson · 2016 · The Laryngoscope
44. Comparison of Simulated Treatment and Cost-effectiveness of a Stepped Care Case-Finding Intervention vs Usual Care for Posttraumatic Stress Disorder After a Natural Disaster
    Gregory H. Cohen, Shailesh Tamrakar, Sarah Ryan Lowe, Laura Sampson, Catherine K. Ettman, Benjamin Paul Linas, Kenneth J. Ruggiero, Sandro Galea · 2017 · JAMA Psychiatry
45. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis
    William C. Brown, Brent Anthony Senior · 2020 · Current Allergy and Asthma Reports
46. The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance
    Bettina Butzke, Fuat S. Oduncu, Franziska Severin, Arne Pfeufer, Volker Heinemann, Clemens Gießen-Jung, Björn Stollenwerk, Wolf H. Rogowski · 2015 · Acta Oncologica
47. Cost-effectiveness of Chlamydia Vaccination Programs for Young Women
    Kwame Owusu‐Edusei, Harrell W. Chesson, Thomas L. Gift, Robert C. Brunham, GAIL A. BOLAN · 2015 · Emerging infectious diseases
48. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
    Vivek Yerrapu Reddy, Ronald L. Akehurst, Stacey L. Amorosi, Meghan B. Gavaghan, Deanna S. Hertz, David R. Holmes · 2018 · Stroke
49. Cost-Effectiveness of Using Standardized Patients to Assess Student-Pharmacist Communication Skills
    Chris Gillette, Robert Brewster Stanton, Nicole Rockich‐Winston, Michael J. Rudolph, H. Glenn Anderson · 2017 · American Journal of Pharmaceutical Education
50. When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives
    Scott Dennis Grosse · 2015 · Healthcare
51. The Relative Net Health Benefit of Liver Resection, Ablation, and Transplantation for Early Hepatocellular Carcinoma
    Gaya Spolverato, Alessandro Vitale, Aslam M. Ejaz, Yuhree Kim, Shishir Kumar Maithel, David Cosgrove, Timothy Michael Pawlik · 2015 · World Journal of Surgery
52. QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique
    Scott Dennis Grosse, Lisa A. Prosser, Keiko Asakawa, David H Feeny · 2010 · Expert Review of Pharmacoeconomics & Outcomes Research
53. Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis
    Scott Dennis Grosse · 2015 · Healthcare
54. A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia
    Bilal I. Chughtai, Sirikan Rojanasarot, Kurt Neeser, Dmitry Gultyaev, Shuai Fu, Samir Bhattacharyya, Ahmad M. El-Arabi, Ben Cutone, Kevin T. McVary · 2022 · PLoS ONE
55. Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis
    Shouki N. Bazarbashi, Edward B. De Vol, Fatma Maraiki, Ahmed H. Al-Jedai, Afshan A. Ali, Ali Alhammad, Ibrahim Abdulrahman Aljuffali, Michaël Iskedjian · 2020 · PharmacoEconomics - Open
56. Potential impact of vaccination againstNeisseria meningitidisonNeisseria gonorrhoeaein the United States: Results from a decision-analysis model
    Stéphane A. Régnier, Jasper Huels · 2014 · Human Vaccines & Immunotherapeutics
57. Respiratory syncytial virus immunization program for the United States: Impact of performance determinants of a theoretical vaccine
    Stéphane A. Régnier · 2013 · Vaccine
58. Cost-effectiveness of professional pharmacy services in community pharmacy: a systematic review
    Amaia Malet‐Larrea, Victoria García‐Cárdenas, Loreto Sáez‐Benito, Shalom I. Benrimoj, B Calvo, Estíbaliz Goyenechea · 2016 · Expert Review of Pharmacoeconomics & Outcomes Research
59. Economics of Self-Measured Blood Pressure Monitoring: A Community Guide Systematic Review
    Verughese Jacob, Sajal K. Chattopadhyay, Krista K. Proia, David P. Hopkins, Jeffrey A. Reynolds, Anilkrishna Bjorn Thota, CHRIS D. JONES, Daniel T. Lackland, Kimberly J. Rask, Nicolaas P. Pronk et al. · 2017 · American Journal of Preventive Medicine
60. Is Less Really More? Economic Evaluation of Minimally Invasive Surgery
    Andrew S. Chung, Alexander M. Ballatori, Brandon Ortega, Elliot Min, Blake G. Formanek, John Liu, Patrick C. Hsieh, Raymond J. Hah, Jeffrey C. Wang, Zorica Buser · 2020 · Global Spine Journal
61. Cost-Utility Analyses of Cognitive-Behavioural Therapy of Depression: A Systematic Review
    Christian Brettschneider, Helei Djadran, Martin Christian Härter, Bernd Löwe, Steffi Gerlinde Riedel-Heller, Hans‐Helmut König · 2014 · Psychotherapy and Psychosomatics
62. The Cost Effectiveness of the DIEP Flap Relative to the Muscle-Sparing TRAM Flap in Postmastectomy Breast Reconstruction
    Naveen M. Krishnan, Chad Allen Purnell, Maurice Y. Nahabedian, Gary Lee Freed, John F. Nigriny, Joseph M. Rosen, Gedge D. Rosson · 2015 · Plastic & Reconstructive Surgery
63. Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist
    Brett Doble, Marcus Tan, Anthony Harris, Paula Kate Lorgelly · 2014 · Expert Review of Molecular Diagnostics
64. Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
    Soyon Lee, Moise W. Anglade, Joy Meng, Kelly Hagstrom, Jeffrey Kluger, Craig Ian Coleman · 2012 · Circulation Cardiovascular Quality and Outcomes
65. COST-UTILITY ANALYSIS OF NT-PROBNP-GUIDED MULTIDISCIPLINARY CARE IN CHRONIC HEART FAILURE
    Deddo Moertl, Sabine Steiner, Doug Coyle, Rudolf Berger · 2012 · International Journal of Technology Assessment in Health Care
66. Prehospital Triage Strategies for the Transportation of Suspected Stroke Patients in the United States
    Esmée Venema, James Francis Burke, Bob Roozenbeek, Jason Nelson, Hester Floor Lingsma, Diederik W.J. Dippel, David M. Kent · 2020 · Stroke
67. Treatment of Ulnar Neuropathy at the Elbow: Cost–Utility Analysis
    Jae W. Song, Kevin C. Chung, Lisa A. Prosser · 2012 · The Journal Of Hand Surgery
68. Examining the Cost-Effectiveness of Radiation Therapy Among Older Women With Favorable-Risk Breast Cancer
    Sounok Sen, Shi‐Yi Wang, Pamela R. Soulos, Kevin D. Frick, Jessica B. Long, Kenneth B. Roberts, James B. Yu, Suzanne B. Evans, Anees B. Chagpar, Cary Philip Gross · 2014 · JNCI Journal of the National Cancer Institute
69. Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma
    Abdulaali R. Almutairi, Nimer S. Alkhatib, Mok Oh, Clara N. Curiel‐Lewandrowski, Hani M. Babiker, Lee D. Cranmer, Ali McBride, Ivo L Abraham · 2018 · JAMA Dermatology
70. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand
    Khachapon Nimdet, Surachat Ngorsuraches · 2015 · BMJ Open
71. The cost effectiveness of screening newborns for congenital adrenal hyperplasia
    Yoo, B.K., Grosse, S.D. · 2009 · Public Health Genomics
72. The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer
    Florian Koerber, Raphaela M. Waidelich, Björn Stollenwerk, Wolf H. Rogowski · 2014 · BMC Health Services Research
73. Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States
    Veena Shankaran, Jesse D. Ortendahl, Anna Purdum, Björn Bolinder, Ayanna M Anene, Gordon H. Sun, Tanya G. K. Bentley · 2015 · American Journal of Clinical Oncology
74. Cost-Effectiveness Comparison Between Topical Silver Sulfadiazine and Enclosed Silver Dressing for Partial-Thickness Burn Treatment
    Clifford Charles Sheckter, Michael M. Van Vliet, Naveen M. Krishnan, Warren Louis Garner · 2013 · Journal of Burn Care & Research
75. The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland’s Health System?
    James F. O’Mahony, Diarmuid Coughlan · 2015 · PharmacoEconomics
76. Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes
    Maxwell Ogochukwu Adibe, Cletus Nze Aguwa, Chinwe Victoria Ukwe · 2013 · Value in Health Regional Issues
77. A Person Trade-Off Study to Estimate Age-Related Weights for Health Gains in Economic Evaluation
    Stavros Petrou, Ngianga‐Bakwin Kandala, Angela Robinson, Rachel Mairi Baker · 2013 · PharmacoEconomics
78. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New “Fast-Second Winner” Strategy
    Konstantinos A. Mitropoulos, D.N. Cooper, Christina Mitropoulou, Spiros Nicolas Agathos, Juergen K. V. Reichardt, Fatma Al‐Maskari, Wasun Chantratita, Ambroise Wonkam, Collet Dandara, Θεοδώρα Κάτσιλα et al. · 2017 · OMICS A Journal of Integrative Biology
79. A Cost-Utility Analysis Comparing Oncoplastic Breast Surgery to Standard Lumpectomy in Large Breasted Women
    Abhishek Chatterjee, Anaeze Chidiebele Offodile, Ammar A. Asban, Raquel A. Minasian, Albert Losken M. D, Roger A. Graham, Lilian Chen, Brian J. Czerniecki, Carla Suzanne Fisher · 2018 · Advances in Breast Cancer Research
80. A review of the cost-effectiveness of adult influenza vaccination and other preventive services
    Nazila Dabestani, Andrew J. Leidner, Eric E. Seiber, Hyoshin Kim, Samuel B. Graitcer, Ivo Foppa, Carolyn Buxton Bridges · 2019 · Preventive Medicine
81. A Simplified Cost-Utility Analysis of Inpatient Flap Monitoring after Microsurgical Breast Reconstruction and Implications for Hospital Length of Stay
    Eric M. Jablonka, Andreas M. Lamelas, Suhail Kanchwala, Irfan A. Rhemtulla, Mark L. Smith · 2019 · Plastic & Reconstructive Surgery
82. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis
    Stephen Mac, Tiffany Fitzpatrick, Jennie Johnstone, Beate Sander · 2019 · Antimicrobial Resistance and Infection Control
83. A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
    Alyson W. Wong, John Koo, Christopher J. Ryerson, Mohsen Sadatsafavi, Wenjia Chen · 2022 · BMC Pulmonary Medicine
84. Cost-Effectiveness Analysis of Qsymia for Weight Loss
    Eric Andrew Finkelstein, Eliza Kruger, Sunil Karnawat · 2014 · PharmacoEconomics
85. How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI
    Olivia Oxlade, Márcia Pinto, Anete Trajman, Dick Menzies · 2013 · PLoS ONE
86. Surgical management of bilateral vocal fold paralysis: A cost‐effectiveness comparison of two treatments
    Matthew Roberts Naunheim, Phillip C. Song, Ramon Arturo Franco, Blake Christian Alkire, Mark G. Shrime · 2016 · The Laryngoscope
87. A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with free flap reconstruction in the treatment of breast cancer
    Abhishek Chatterjee, Ammar A. Asban, Michael M. Jonczyk, Lilian Chen, Brian J. Czerniecki, Carla Suzanne Fisher · 2019 · The American Journal of Surgery
88. A primer on cost-effectiveness in the allergy clinic
    Marcus S Shaker, Matthew Greenhawt · 2019 · Annals of Allergy Asthma & Immunology
89. Cost-Effectiveness of Cardiac Rehabilitation in Patients with Coronary Artery Disease: A Meta-Analysis
    Tomoyuki Takura, Nozomi Ebata, Yoichi Goto, Masahiro Kohzuki, Masatoshi Nagayama, Keiko Oikawa, Teruyuki Koyama, Haruki Itoh · 2019 · Cardiology Research and Practice
90. The QALY at 50: One story many voices
    Anne E. Spencer, Oliver Rivero‐Arias, Ruth Wong, Aki Tsuchiya, Han Bleichrodt A, Rhiannon Tudor Edwards, Richard Norman, Andrew J. Lloyd, Philip Clarke · 2021 · Social Science & Medicine
91. Cost-effectiveness of decompressive craniectomy in traumatic brain injuries
    Kirsi Malmivaara, Riku P. Kivisaari, Juha Antero Hernesniemi, Jari O. Siironen · 2010 · European Journal of Neurology
92. A Cost-Utility Analysis of the Use of Preoperative Computed Tomographic Angiography in Abdomen-Based Perforator Flap Breast Reconstruction
    Anaeze Chidiebele Offodile, Abhishek Chatterjee, Sergio A. Vallejo, Carla Suzanne Fisher, Julia C. Tchou, Lifei Guo · 2014 · Plastic & Reconstructive Surgery
93. A Systematic Review of Economic Studies on Biological Agents Used to Treat Crohn’s Disease
    Derek H. Tang, Amanda R. Harrington, Jeannie K. Lee, Mark Lin, Edward P. Armstrong · 2013 · Inflammatory Bowel Diseases
94. Cost and Clinical Outcome of Adolescent Idiopathic Scoliosis Surgeries—Experience From a Nonprofit Community Hospital
    Anthony E. Bozzio, Xiaobang Hu, Isador H. Lieberman · 2019 · The International Journal of Spine Surgery
95. Cost-Effectiveness of Transfers to Centers With Neurological Intensive Care Units After Intracerebral Hemorrhage
    Jeffrey James Fletcher, Vikas Kotagal, Aaron Gerald Mammoser, Mark D. Peterson, Lewis B. Morgenstern, James Francis Burke · 2014 · Stroke
96. Medical innovation and the sustainability of health systems: A historical perspective on technological change in health
    Pascale Lehoux, Federico Roncarolo, Robson Rocha de Oliveira, Hudson Pacifico da Silva · 2016 · Health Services Management Research
97. Cost‐Utility Analysis of Biologic Treatments for Moderate‐to‐Severe Crohn's Disease
    Derek H. Tang, Edward P. Armstrong, Jeannie K. Lee · 2012 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
98. Cost-effectiveness of Stapedectomy vs Hearing Aids in the Treatment of Otosclerosis
    Danielle M. Gillard, Jeffrey P. Harris · 2019 · JAMA Otolaryngology–Head & Neck Surgery
99. Cost-effectiveness of internet-based cognitive behavior therapy for obsessive-compulsive disorder: results from a randomized controlled trial
    E. Andersson, E. Hedman, B. Ljótsson, Maja Wikström, Elin Elveling, N. Lindefors, G. Andersson, V. Kaldo, C. Rück · 2015 · Journal of Obsessive-Compulsive and Related Disorders
100. Incremental benefits and cost of coordinated anxiety learning and management for anxiety treatment in primary care
     Jutta M. Joesch, Cathy Donald Sherbourne, Greer Sullivan, Murray B. Stein, Michelle G. Craske, Peter Roy‐Byrne · 2011 · Psychological Medicine